Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 3—March 2020
CME ACTIVITY - Research

Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015–2017

Meghana P. ParikhComments to Author , Rany Octaria, and Marion A. Kainer
Author affiliations: Tennessee Department of Health, Nashville, Tennessee, USA (M.P. Parikh, R. Octaria, M.A. Kainer); Vanderbilt University, Nashville (R. Octaria)

Main Article

Table 3

Selected characteristics of patients with injection drug use–related methicillin-resistant Staphylococcus aureus bloodstream infections, by onset type, Tennessee, USA, 2015–2017*

Characteristic MRSA onset
p value Overall
CO-ED CO-IP HO
Total
1,156 (62.9)
572 (31.1)
111 (6.0)
<0.001
1,839 (100)
Onset year <0.001
2015 192 (51.2) 153 (40.8) 30 (8.0) 375 (20.4)
2016 393 (61.1) 211 (32.8) 39 (6.1) 643 (35.0)
2017
571 (69.5)
208 (25.3)
42 (5.1)

821 (44.6)
Age range, y <0.001
13–17 0 1 (0.2) 0 1 (0.0)
18–34 431 (37.3) 164 (28.7) 22 (19.8) 617 (33.6)
35–49 405 (35.0) 226 (39.5) 34 (30.6) 665 (36.2)
50–64 245 (21.2) 149 (26.0) 42 (37.8) 436 (23.7)
>65 75 (6.5) 32 (5.6) 13 (11.7) 120 (6.5)
Median (Q1–Q3)
38 (31–51)
42 (33–52)
49 (37–59)
<0.001

Race <0.001
White 1,059 (91.6) 501 (87.6) 75 (67.6) 1,635 (88.9)
Black 83 (7.2) 56 (9.8) 29 (26.1) 168 (9.1)
Other 6 (0.5) 7 (1.2) 2 (1.8) 15 (0.8)
Unknown
8 (0.7)
8 (1.4)
5 (4.5)

21 (1.1)
Insurance 0.001
Commercial 69 (6.0) 32 (5.6) 8 (7.2) 109 (5.9)
Medicaid 347 (30.0) 192 (33.6) 31 (27.9) 570 (31.0)
Medicare 256 (22.1) 154 (26.9) 42 (37.8) 452 (24.6)
Self-pay/uninsured 422 (36.5) 164 (28.7) 26 (23.4) 612 (33.3)
Other/unknown 62 (5.4) 30 (5.2) 4 (3.6) 96 (5.2)

*Values are no. (%) except as indicated. CO, community onset; ED, emergency department; HO, hospital onset; IP, inpatient.

Main Article

Page created: February 12, 2020
Page updated: February 12, 2020
Page reviewed: February 12, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external